NK Defense and Therapy (FP6)
NK Defense and Therapy
Full title: Natural Killer Cell-Mediated Anti-Viral and Anti Tumor Defense and Therapy: Integrated research training in molecular medicine, bioinformatics and issues of biotech patents and SME business
Grantor: European Commission: 6th Framework Programme (FP6)
Grantor's website: http://cordis.europa.eu/fp6/
Programme: Marie Curie Research Training Networks
Programme website: http://cordis.europa.eu/mariecurie-actions/rtn/home.html
Duration: 2006-2009
Coordinator: Erhard Hofer, Medical University of Vienna, Austria
No. of participants: 11
Partner from the Center for Proteomics: Stipan Jonjic
Project website: http://www.nkdefense.eu/
Brief description:
The general objective of this project was to establish a research training network of postgraduate students and early post-doctoral fellows, to perform basic research on molecular mechanisms of innate immune responses to viruses and tumors, to translate the findings obtained in collaboration with an SME to immunotherapies for evaluation in animal models, to provide top level training of the participating students in the MD/PhD programs of the respective universities as well as to offer an intensive training in state-of-the-art bioinformatics and focused courses on biotech intellectual property rights and on management of SME biotech business.
In frame of this project the Faculty of Medicine University of Rijeka in 2007 employed a PhD student, Indian citizen, who was trained for 31 months at the Department of Histology and Embryology and the Center for Proteomics. In addition, one Marie Curie PhD student affiliated to one of the partner institutions on this project (Heinrich-Heine-University Düsseldorf, Germany) paid a one-month visit to the Center for Proteomics to acquire specific skills related to mAb development. In the final project year three early-stage researchers from the Center for Proteomics and the Department of Histology and Embryology were trained for over three months at the partner institutions (Heinrich-Heine-University Düsseldorf, Germany; Hebrew University - Hadassah Medical School Jerusalem, Israel and Vienna University of Economics and Business, Austria). At the same time, early-stage researchers from the Hebrew University Jerusalem, Israel, and the Medical Faculty of the University of Sarajevo, Bosnia and Herzegovina, were trained for three months at the Center for Proteomics.
